BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33429228)

  • 1. Detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies.
    Leclerc D; Staats Pires AC; Guillemin GJ; Gilot D
    Curr Opin Immunol; 2021 Jun; 70():15-26. PubMed ID: 33429228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression.
    Matheus LHG; Dalmazzo SV; Brito RBO; Pereira LA; de Almeida RJ; Camacho CP; Dellê H
    BMC Cancer; 2020 Sep; 20(1):869. PubMed ID: 32907554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic responses and aryl hydrocarbon receptor novel pathway of mast cell activation.
    Sibilano R; Pucillo CE; Gri G
    Mol Immunol; 2015 Jan; 63(1):69-73. PubMed ID: 24656327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
    Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
    Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The aryl hydrocarbon receptor promotes inflammation-induced dedifferentiation and systemic metastatic spread of melanoma cells.
    Mengoni M; Braun AD; Gaffal E; Tüting T
    Int J Cancer; 2020 Nov; 147(10):2902-2913. PubMed ID: 32790916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.
    Du L; Xing Z; Tao B; Li T; Yang D; Li W; Zheng Y; Kuang C; Yang Q
    Signal Transduct Target Ther; 2020 Feb; 5(1):10. PubMed ID: 32296044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Immune Responses by Nutritional Ligands of Aryl Hydrocarbon Receptor.
    De Juan A; Segura E
    Front Immunol; 2021; 12():645168. PubMed ID: 34093534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.
    Moyer BJ; Rojas IY; Murray IA; Lee S; Hazlett HF; Perdew GH; Tomlinson CR
    Toxicol Appl Pharmacol; 2017 May; 323():74-80. PubMed ID: 28336214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine.
    Campesato LF; Budhu S; Tchaicha J; Weng CH; Gigoux M; Cohen IJ; Redmond D; Mangarin L; Pourpe S; Liu C; Zappasodi R; Zamarin D; Cavanaugh J; Castro AC; Manfredi MG; McGovern K; Merghoub T; Wolchok JD
    Nat Commun; 2020 Aug; 11(1):4011. PubMed ID: 32782249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of T
    de Lima KA; Donate PB; Talbot J; Davoli-Ferreira M; Peres RS; Cunha TM; Alves-Filho JC; Cunha FQ
    Cell Death Dis; 2018 Nov; 9(11):1130. PubMed ID: 30425241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling.
    DiNatale BC; Murray IA; Schroeder JC; Flaveny CA; Lahoti TS; Laurenzana EM; Omiecinski CJ; Perdew GH
    Toxicol Sci; 2010 May; 115(1):89-97. PubMed ID: 20106948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herbal Plants: The Role of AhR in Mediating Immunomodulation.
    Bungsu I; Kifli N; Ahmad SR; Ghani H; Cunningham AC
    Front Immunol; 2021; 12():697663. PubMed ID: 34249001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.
    Opitz CA; Litzenburger UM; Sahm F; Ott M; Tritschler I; Trump S; Schumacher T; Jestaedt L; Schrenk D; Weller M; Jugold M; Guillemin GJ; Miller CL; Lutz C; Radlwimmer B; Lehmann I; von Deimling A; Wick W; Platten M
    Nature; 2011 Oct; 478(7368):197-203. PubMed ID: 21976023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo(a)pyrene Enhanced Dermatophagoides Group 1 (Der f 1)-Induced TGFβ1 Signaling Activation Through the Aryl Hydrocarbon Receptor-RhoA Axis in Asthma.
    Wang E; Tu W; Do DC; Xiao X; Bhatti SB; Yang L; Sun X; Xu D; Yang P; Huang SK; Gao P; Liu Z
    Front Immunol; 2021; 12():643260. PubMed ID: 33936062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous ligands of the aryl hydrocarbon receptor regulate lung dendritic cell function.
    Thatcher TH; Williams MA; Pollock SJ; McCarthy CE; Lacy SH; Phipps RP; Sime PJ
    Immunology; 2016 Jan; 147(1):41-54. PubMed ID: 26555456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
    Cheong JE; Sun L
    Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
    Sadik A; Somarribas Patterson LF; Öztürk S; Mohapatra SR; Panitz V; Secker PF; Pfänder P; Loth S; Salem H; Prentzell MT; Berdel B; Iskar M; Faessler E; Reuter F; Kirst I; Kalter V; Foerster KI; Jäger E; Guevara CR; Sobeh M; Hielscher T; Poschet G; Reinhardt A; Hassel JC; Zapatka M; Hahn U; von Deimling A; Hopf C; Schlichting R; Escher BI; Burhenne J; Haefeli WE; Ishaque N; Böhme A; Schäuble S; Thedieck K; Trump S; Seiffert M; Opitz CA
    Cell; 2020 Sep; 182(5):1252-1270.e34. PubMed ID: 32818467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aryl hydrocarbon receptor control of adaptive immunity.
    Quintana FJ; Sherr DH
    Pharmacol Rev; 2013; 65(4):1148-61. PubMed ID: 23908379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
    Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
    Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective suppression of the human aryl hydrocarbon receptor function can be mediated through binding interference at the C-terminal half of the receptor.
    Ren L; Thompson JD; Cheung M; Ngo K; Sung S; Leong S; Chan WK
    Biochem Pharmacol; 2016 May; 107():91-100. PubMed ID: 26970402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.